Subscriber Login

Forgotten your password?

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

OAB, LUTS, and BPH—a paradigm shift 

Chapter:
OAB, LUTS, and BPH—a paradigm shift
Author(s):

Alexander Roosen

DOI:
10.1093/med/9780199572779.003.0006

• “Overactive bladder” is a merely clinical diagnosis, comprising urgency, with or without urge incontinence (OAB-wet and OAB-dry), and either or both frequency and nocturia • “Detrusor overactivity” (DO) is a urodynamic finding which may or may not underlay OAB, and has two types: phasic and terminal DO, the latter usually being of neurogenic origin • “LUTS” comprise storage/OAB symptoms, voiding symptoms, and postmicturition symptoms. They equally affect men and women and are rather age- than gender-related • In female OAB, antimuscarinics should be applied for 6–12 weeks before commencing invasive diagnostics. In the male, A1-receptor antagonists should first be tried alone, followed by a combination with antimuscarinics.

Oxford Medicine requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us.